Search research articles
Contact Us
Filters
Showing results (121-130 of 457) with videos related to
Page
of 46
Sort By:
JAMA Cardiology
|
November 14, 2019
Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial
Subodh Verma, Stephen C Bain, John B Buse, et al.
Diabetes, Obesity & Metabolism
|
August 5, 2025
Risk of suicidal ideation and suicidality among adults prescribed semaglutide for weight management: A population-based cohort study
Qoua L Her, Tiansheng Wang, Til Stürmer, et al.
Diabetes Care
|
August 20, 2015
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
John B Buse, Ralph A DeFronzo, Julio Rosenstock, et al.
Diabetes Care
|
January 1, 2008
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
David M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care
|
October 24, 2008
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care
|
July 10, 2020
Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure
Mugdha Gokhale, Stacie B Dusetzina, Virginia Pate, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 16, 2024
Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians
Thomas R Pieber, Jennifer Leohr, Juliana M Bue-Valleskey, et al.
Diabetes, Obesity & Metabolism
|
May 16, 2019
Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetes
Elizabeth M Garry, John B Buse, Mugdha Gokhale, et al.
Diabetes, Obesity & Metabolism
|
January 31, 2019
Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers
Jeff Y Yang, Tiansheng Wang, Virginia Pate, et al.
Pharmacoepidemiology and Drug Safety
|
June 27, 2018
Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugs
Mugdha Gokhale, John B Buse, Christina DeFilippo Mack, et al.
Page
of 46
Search research articles
Search
Showing results (121-130 of 457) with videos related to
Sort By:
Page
of 46
JAMA Cardiology
|
November 14, 2019
Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial
Subodh Verma, Stephen C Bain, John B Buse, et al.
Diabetes, Obesity & Metabolism
|
August 5, 2025
Risk of suicidal ideation and suicidality among adults prescribed semaglutide for weight management: A population-based cohort study
Qoua L Her, Tiansheng Wang, Til Stürmer, et al.
Diabetes Care
|
August 20, 2015
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
John B Buse, Ralph A DeFronzo, Julio Rosenstock, et al.
Diabetes Care
|
January 1, 2008
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
David M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care
|
October 24, 2008
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care
|
July 10, 2020
Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure
Mugdha Gokhale, Stacie B Dusetzina, Virginia Pate, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 16, 2024
Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians
Thomas R Pieber, Jennifer Leohr, Juliana M Bue-Valleskey, et al.
Diabetes, Obesity & Metabolism
|
May 16, 2019
Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type-2 diabetes
Elizabeth M Garry, John B Buse, Mugdha Gokhale, et al.
Diabetes, Obesity & Metabolism
|
January 31, 2019
Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers
Jeff Y Yang, Tiansheng Wang, Virginia Pate, et al.
Pharmacoepidemiology and Drug Safety
|
June 27, 2018
Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugs
Mugdha Gokhale, John B Buse, Christina DeFilippo Mack, et al.
Page
of 46